[Development, experimental and clinical testing of an antirheumatic combination].
D000632:Aminopyrine / Q000008:administration & dosage*; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage*; D001835:Body Weight; D002351:Carrageenan / Q000009:adverse effects; D003911:Dextrans / Q000009:adverse effects; D004487:Edema / Q000139:chemically induced / Q000188:drug therapy; D004890:Erythema / Q000188:drug therapy / Q000209:etiology; D006614:Hindlimb; D006801:Humans; D007273:Injections, Intramuscular; D007274:Injections, Intraperitoneal; D007592:Joint Diseases / Q000188:drug therapy*; D008297:Male; D051381:Rats; D012457:Salicylamides / Q000008:administration & dosage*; D012997:Solvents; D014466:Ultraviolet Rays
D000893:Anti-Inflammatory Agents; D003911:Dextrans; D012457:Salicylamides; D012997:Solvents; D000632:Aminopyrine; D002351:Carrageenan
Entwicklung, experimentelle und klinische Prüfung einer antirheumatischen Kombination.